Home › Therapeutic areas › Oncology › Gastroesophageal Junction Cancer

Gastroesophageal Junction Cancer (3 companies)

Companies with an active program in Gastroesophageal Junction Cancer.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CTMX CytomX Therapeutics Oncology 1 Phase 1 $423M 7
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved $2.59B 28
ZYME Zymeworks OncologyRespiratory 1 Approved $1.78B 12